Haemonetics Corporation (HAE) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $92.13 +0.86%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Haemonetics Corporation (NYSE: HAE) reported Q3 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $231.8 million versus the consensus estimate of $234.85 million.
For earnings history and earnings-related data on Haemonetics Corporation (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
